Alice D. Marinho

MD from @UNIRIO_Oficial 🇧🇷 | English, Portuguese, French | Interested in Oncology 🦀 | 🧬🏝⚽🏃🏻‍♀🛫🏎

[Alice D. Marinho @alicedmarinho]

My first poster at ASCO! Thank you to everyone who stopped by to discuss Niraparib in ovarian cancer. Special thanks to @MaysaVilbert, the best mentor! #ASCO24

[Alice D. Marinho @alicedmarinho]

Our findings showed that home-based monitoring significantly reduced mortality and hospitalization rates when compared with usual care! Out now in @eClinicalMed @TheLancet

[Mariana Clemente @Marianaclemed]

Thrilled to share our latest research about the long-term impact of home-based monitoring after an admission for acute
decompensated heart failure.

Published in @eClinicalMed:
https://t.co/rVRv8PyeRq

[Alice D. Marinho @alicedmarinho]

Our latest meta-analysis on the use of T-DXd among patients with breast cancer brain metastasis showed durable PFS and > 50% intracranial objective response rate! Out now on @ESMO_Open

[ESMO Open @ESMO_Open]

In a meta-analysis of 10 studies by Michelin et al, published on @ESMO_Open, T-DXd was found associated with relevant intracranial activity among patients with breast cancer brain metastases (IC-ORR 61%, mPFS 15 months). Read the article here: https://t.co/MAlrP1Zsjs

[Alice D. Marinho @alicedmarinho]

@Lhcampedelli @felipebatalini The next poster will be ours ☘️🤩

[Alice D. Marinho @alicedmarinho]

I’m honored to be presenting my first poster at a #BreastCancer conference! Special thank you to my mentor, Dr. @felipebatalini. #SABCS22 #MedTwitter

[Alice D. Marinho @alicedmarinho]

@Lucas_Mitre_ @felipebatalini Thank you so much! 🇧🇷😁

[Alice D. Marinho @alicedmarinho]

@BrandaoGR @felipebatalini Proud of us! 💖

[Alice D. Marinho @alicedmarinho]

Dr. Ian Krop is now presenting new data on Trastuzumab deruxtecan! T-DXd improves PFS and OS vs TPC in patients with HER2+ mBC previously treated with T-DM1. #SABCS22 #BreastCancer @SABCSSanAntonio @AACR

[Alice D. Marinho @alicedmarinho]

First day of #SABCS22! @DrDawnHershman is now presenting “How to measure and improve drug adherence in clinical trials”. @SABCSSanAntonio @AACR

[Alice D. Marinho @alicedmarinho]

@IsabeleMiyawaki @escardio @SABCSSanAntonio @AACR Super excited for you! See you in San Antonio! ☘️🤩

[Alice D. Marinho @alicedmarinho]

Plane tickets bought! ✅ Excited to be attending my first #Oncology conference in the US and presenting a poster as a first author in #SABCS22 @SABCSSanAntonio @AACR 🤩

[Alice D. Marinho @alicedmarinho]

I am overjoyed to be an author of a history of surgery poster in #ACSCC22 🥳. Even though I want to pursue an IM residency, I am very proud of my country and wanted to showcase its history by highlighting Dr. Ivo Pitanguy, a pioneering Brazilian plastic surgeon 🤩 @AmCollSurgeons

[Alice D. Marinho @alicedmarinho]

Me thinking “making a scientific poster is going to be easy. All the writing is already done, now I just have to put it nicely in a rectangle”. I just spent 1 hour trying to find the perfect shade of blue. 😀 #MedTwitter

[Alice D. Marinho @alicedmarinho]

Half of Medical School is done (3/6) ✅. After 3 years of a lot of dedication, I got to take my picture with this beautiful stained glass of 3 giants of Medicine - Louis Pasteur, Oswaldo Cruz, and Paul Ehrlich. Plenty of great things to come in the next 3 years! #MedTwitter

[Alice D. Marinho @alicedmarinho]

As an aspiring Oncologist, it is incredible to see the results of DESTINY-04 and the changes in the treatment of advanced breast cancer. Hoping to attend #ASCO next year in person!

[George W Sledge MD @GeorgeSledge51]

#ASCO2022 Destiny-04. ILD as expected. My thoughts: best in show for breast cancer this year. HER2-low now on the table for ADCs as a class. There is an accompanying NEJM paper. The audience goes wild in a way I have not seen since the HER2 2005 rock concert. Congrats to Dr Modi.

[Alice D. Marinho @alicedmarinho]

It's a huge honor to be a part of this with you guys. Very excited about what's coming next! 🤩

[Victor Perim @VictorPerimMD]

🤓Big researcher breakthrough moment yesterday: had my first Forest Plot graph constructed from zero.

All of our research team had a smile on their face as the graph appeared on the screen.

Great things are coming…

@alicedmarinho @beatrizdmarinho @Lhcampedelli

#MedTwitter

[Alex Ritter, PhD @AlexRitterPhD]

Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.

[NEJM Clinician @NEJMClinician]

Rates of progression-free survival were significantly higher with trastuzumab deruxtecan than with trastuzumab-emtansine in patients with metastatic, HER2-positive #breastcancer: https://t.co/7snP9bR2MP @NEJM @DrWGradishar

[Alice D. Marinho @alicedmarinho]

@m_gdavid @leitaomd @Lacog_group I think @Lacog_group recorded it!

[Alice D. Marinho @alicedmarinho]

Incredible presentation today about lymph node assessment and lymphadenectomy in endometrial cancer with Dr. Mario Leitão @leitaomd @Lacog_group #Oncology 👏

[Lobke Marsden @lobke_marsden]

Ready for a little girl to start her #radiotherapy treatment as Elsa 💙❄️😊
#ChildhoodCancer #NHS